More articles from Editorial

You have access
Is Actinium Really Happening?
Richard Zimmermann

Journal of Nuclear Medicine October 1, 2023, 64 (10) 1516-1518; DOI: https://doi.org/10.2967/jnumed.123.265907
You have access
An Opinion on ChatGPT in Health Care—Written by Humans Only
Jens Kleesiek, Yonghui Wu, Gregor Stiglic, Jan Egger and Jiang Bian

Journal of Nuclear Medicine May 1, 2023, 64 (5) 701-703; DOI: https://doi.org/10.2967/jnumed.123.265687
You have access
Clinical Implementation of ¹⁷⁷Lu-PSMA-617 in the United States: Lessons Learned and Ongoing Challenges
Praful Ravi, Bridget Whelpley, Emma Kelly, Andrew Wolanski, Jolivette Ritzer, Matthew Robertson, Hina Shah, Alicia K. Morgans, Xiao X. Wei, Rajitha Sunkara, Mark Pomerantz, Mary-Ellen Taplin, Kerry L. Kilbridge, Atish D. Choudhury and Heather Jacene

Journal of Nuclear Medicine March 1, 2023, 64 (3) 349-350; DOI: https://doi.org/10.2967/jnumed.122.265194
You have access
Prostate Cancer Theranostics: Concurrent Approvals by the Food and Drug Administration of the First Diagnostic Imaging Drug Indicated to Select Patients for a Paired Radioligand Therapeutic Drug
A. Alex Hofling, Anthony F. Fotenos, Gang Niu, Jaleh Fallah, Sundeep Agrawal, Sue-Jane Wang and Libero Marzella

Journal of Nuclear Medicine November 1, 2022, 63 (11) 1642-1643; DOI: https://doi.org/10.2967/jnumed.122.264299
You have access
Role of Prostate-Specific Membrane Antigen PET in Metastatic Prostate Cancer: We Have the Answers
Kelsey L. Pomykala, Ken Herrmann, Anwar R. Padhani, Michael S. Hofman, Elisabetta Lalumera and Stefano Fanti

Journal of Nuclear Medicine October 1, 2022, 63 (10) 1480-1481; DOI: https://doi.org/10.2967/jnumed.122.264394
You have access
Radionuclide Evaluation of Brain Death in the Post-McMath Era: Epilogue and Enigmata
Lionel S. Zuckier

Journal of Nuclear Medicine September 1, 2022, 63 (9) 1323-1325; DOI: https://doi.org/10.2967/jnumed.122.263972
You have access
Why We Did What We Did: PSMA PET/CT Selection Criteria for the VISION Trial
Phillip H. Kuo, Taylor Benson, Richard Messmann and Michael Groaning

Journal of Nuclear Medicine June 1, 2022, 63 (6) 816-818; DOI: https://doi.org/10.2967/jnumed.121.263638
You have access
Managing a High-Specific-Activity Iobenguane Therapy Clinic: From Operations to Reimbursement
Sophia R. O’Brien and Daniel A. Pryma

Journal of Nuclear Medicine February 1, 2022, 63 (2) 196-198; DOI: https://doi.org/10.2967/jnumed.121.262306
You have access
Bringing VISION to Nuclear Medicine: Accelerating Evidence and Changing Paradigms with Theranostics
Michael S. Hofman

Journal of Nuclear Medicine December 1, 2021, 62 (12) 1710-1711; DOI: https://doi.org/10.2967/jnumed.121.262890
You have access
Imaging of Small Intestine Neuroendocrine Neoplasms: Is SSTR PET the Holy Grail?
Alessio Imperiale, Leah Meuter, Karel Pacak and David Taïeb

Journal of Nuclear Medicine October 1, 2021, 62 (10) 1347-1348; DOI: https://doi.org/10.2967/jnumed.121.262140

Main menu

User menu

Search

More articles from Editorial

Pages